Press Releases
2018, MLS receives special innovation prize at Hi-Europe
In 2018, Magellan Life Science was awarded a special prize from Naturex Ingenium at the Hi-Europe Frankfurt, Germany (Now Fi-Europe) conference.
Read More →
MLS gets chosen for 2018 IndieBio, SOSV's Cohort
SOSV is a global, multi-stage venture capital firm that invests in deep tech startups, starting at pre-seed, and operates the deeply resourced HAX and IndieBio programs in New York, Newark and San Francisco.
Read More →
2020, Roquette Ventures eyes protein sweeteners from MLS
French investment firm Roquette Ventures (part of Roquette Group), which supports start-ups in food, nutrition, and health markets, is looking to scale up production of plant protein sweeteners made using precision fermentation.
Read More →
MLS secures process patent in major markets for Brazzein
MLS has secured broad patent coverage for its proprietary precision respiration process being currently used to scale-up Brazzein. The patent has been granted in the US, UK, India, EU and China. (*Pending Chinese PTO queries).
2025, MLS Scales Up Brazzein
MLS has successfully scaled up Brazzein to pilot scale at its CRO's facility in the UK and is in the process of further scaling up the molecule with the goal of establishing a robust industrial process.
MLS part of 2026 British High Commission's top 20 UK SMEs cohort
In Feb 2026, CPI led a UK Biomanufacturing & Pharma SME delegation in India. Magellan was chosen by the British government amongst the top 20 innovative companies.
Read More →
© 2026 Magellan Life Sciences Ltd. All Rights Reserved